VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $218,000 | -40.8% | 14,995 | 0.0% | 0.12% | +43.8% |
| Q3 2016 | $368,000 | +16.5% | 14,995 | -4.5% | 0.08% | -48.4% |
| Q2 2016 | $316,000 | -23.5% | 15,695 | 0.0% | 0.16% | -20.1% |
| Q1 2016 | $413,000 | -67.5% | 15,695 | +25.6% | 0.19% | -66.8% |
| Q4 2015 | $1,270,000 | -30.9% | 12,495 | +21.3% | 0.58% | -33.7% |
| Q3 2015 | $1,837,000 | +96.9% | 10,300 | +145.2% | 0.88% | +86.3% |
| Q2 2015 | $933,000 | – | 4,200 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |